NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-17
DOI
10.1038/s41598-019-42517-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
- (2018) John E Edwards et al. CLINICAL INFECTIOUS DISEASES
- Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis
- (2018) Priya Uppuluri et al. Frontiers in Immunology
- Go Forth and Colonize: Dispersal from Clinically Important Microbial Biofilms
- (2016) Priya Uppuluri et al. PLoS Pathogens
- Pathogenesis ofCandida albicansbiofilm
- (2016) Christina Tsui et al. Pathogens and Disease
- Candida albicansBiofilms and Human Disease
- (2015) Clarissa J. Nobile et al. Annual Review of Microbiology
- A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance
- (2015) Christopher G Pierce et al. npj Biofilms and Microbiomes
- NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response
- (2013) Ashraf S. Ibrahim et al. VACCINE
- Interactions ofCandida albicanswith host epithelial surfaces
- (2013) David W. Williams et al. Journal of Oral Microbiology
- Self-Adjuvanting Glycopeptide Conjugate Vaccine against Disseminated Candidiasis
- (2012) Hong Xin et al. PLoS One
- NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults
- (2012) Clint S. Schmidt et al. VACCINE
- Vaccine and Monoclonal Antibody That Enhance Mouse Resistance to Candidiasis
- (2011) Hong Xin et al. Clinical and Vaccine Immunology
- The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: A mycological perspective
- (2011) Macit Ilkit et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Active and Passive Immunization with rHyr1p-N Protects Mice against Hematogenously Disseminated Candidiasis
- (2011) Guanpingsheng Luo et al. PLoS One
- Candida albicansHyr1p Confers Resistance to Neutrophil Killing and Is a Potential Vaccine Target
- (2010) Guanpingsheng Luo et al. JOURNAL OF INFECTIOUS DISEASES
- Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle
- (2010) Priya Uppuluri et al. PLoS Pathogens
- Considerable Differences in Vaccine Immunogenicities and Efficacies Related to the Diluent Used for Aluminum Hydroxide Adjuvant
- (2008) L. Lin et al. Clinical and Vaccine Immunology
- Antibody Titer Threshold Predicts Anti‐Candidal Vaccine Efficacy Even though the Mechanism of Protection Is Induction of Cell‐Mediated Immunity
- (2008) Brad Spellberg et al. JOURNAL OF INFECTIOUS DISEASES
- A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing
- (2008) Christopher G Pierce et al. Nature Protocols
- The Hyphal-Associated Adhesin and Invasin Als3 of Candida albicans Mediates Iron Acquisition from Host Ferritin
- (2008) Ricardo S. Almeida et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now